Tilray Inc
Change company Symbol lookup
Select an option...
TLRY Tilray Inc
FDX FedEx Corp
BAC Bank of America Corp
EV Eaton Vance Corp
CBU Community Bank System Inc
FPA First Trust Asia Pacific Ex-Japan AlphaDEX® Fund
GER Goldman Sachs MLP and Energy Renaissance Fund
FNX First Trust Mid Cap Core AlphaDEX® Fund
FNK First Trust Mid Cap Value AlphaDEX® Fund
FMK First Trust Mega Cap AlphaDEX® Fund

Health Care : Pharmaceuticals |
Based in CanadaCompany profile

Tilray Inc is engaged in pharmaceutical sector. The Company is a supplier of cannabis products to pharmaceutical distributors. The Company is focused on medical cannabis research, cultivation, processing and distribution of cannabis products worldwide. Through its subsidiary, FHF Holdings Ltd (Manitoba Harvest) manufactures, markets and distributes hemp-based consumer products. The portfolio of Manitoba Harvest includes Hemp Hearts, Hemp Oil, Hemp Yeah! granola, Hemp Yeah! protein powder and Hemp Bliss milk. It also supplies cannabis products to patients in a number of countries spanning five continents through its subsidiaries in Australia, Canada and Germany and it produces medical cannabis in Canada and Europe.

Closing Price
Day's Change
-3.09 (-4.40%)
B/A Size
Day's High
Day's Low

10-day average volume:



All providers
March 20, 2019
UPDATE: Tilray stock rises after the company shows it can sell recreational pot

By Max A. Cherney Canadian pot producer intends to shift focus to U.S., European markets Tilray Inc. finally showed investors that it is capable of selling recreational pot in Canada, but emphasized its pivot to markets in the U.S. and Europe...(MarketWatch)

UPDATE: Cannabis stocks climb after Tilray's earnings, as New Jersey moves closer to legal weed

By Ciara Linnane, MarketWatch Lawmakers in the Garden State have voted in favor of bills legalizing cannabis for adult recreational use Cannabis stocks were mostly higher Tuesday, as investors digested Tilray Inc.'s earnings and the latest...(MarketWatch)

March 19, 2019
Tilray's stock jumps 3.8% premarket after Q4 results late Monday

(END) Dow Jones Newswires March 19, 2019 06:45 ET (10:45 GMT) Copyright (c) 2019 Dow Jones & Company, Inc.(MarketWatch)

March 18, 2019
UPDATE: Cannabis producer Tilray stock rises after losses widen, revenue tops estimates

Tilray Inc. (TLRY) shares gained more than 4% in the extended session Monday after the cannabis producer reported wider-than-expected losses but beat Wall Street revenue estimates. The company reported fourth-quarter net losses of $31 million, or...(MarketWatch)

UPDATE: Cannabis stocks rally ahead of Tilray earnings

By Ciara Linnane, MarketWatch Curaleaf rallies 8% on news to buy Acres Cannabis, GW Pharma raises $105 million for R&D, launch of Epidiolex in Europe and U.S. Cannabis stocks were higher Monday, as investors reacted to the latest tie-ups in...(MarketWatch)

UPDATE: Tilray earnings: Time to prove it can actually sell some pot

By Max A. Cherney After not selling any recreational marijuana in first two weeks of legal sales in Canada, analysts expect Tilray sold about $14M worth of cannabis in quarter that will be reported Monday (MarketWatch)

March 10, 2019
UPDATE: Cannabis stocks fall as analyst takes bearish stance on Tilray

By Ciara Linnane, MarketWatch Cronos closes Altria deal and adds four new directors to board along with a new finance head Cannabis stocks were mostly lower Friday, after Jefferies started coverage of Tilray Inc. with a bearish underperform...(MarketWatch)

March 08, 2019
UPDATE: Tilray shares fall 7% premarket as Jefferies initiates coverage with underperform rating

Shares of cannabis company Tilray Inc. fell 7% in premarket trade Friday, after the cannabis stock was initiated with an underperform rating by Jefferies, saying it struggles to justify its current valuation. Analyst Owen Bennett assigned the...(MarketWatch)

Tilray shares slide 2.4% premarket

(END) Dow Jones Newswires March 08, 2019 07:02 ET (12:02 GMT) Copyright (c) 2019 Dow Jones & Company, Inc.(MarketWatch)

Tilray assigned price target of $61 by Jefferies

(END) Dow Jones Newswires March 08, 2019 06:59 ET (11:59 GMT) Copyright (c) 2019 Dow Jones & Company, Inc.(MarketWatch)

Tilray initiated as underperform at Jefferies

(END) Dow Jones Newswires March 08, 2019 06:58 ET (11:58 GMT) Copyright (c) 2019 Dow Jones & Company, Inc.(MarketWatch)

March 05, 2019
UPDATE: Here's why marijuana stocks won't get a boost by presidential candidates' legalization bill

By Nigam Arora Market mechanics, such as short squeezes, occasionally throttle the stocks Many investors see a big opportunity in marijuana. Alas, it is not as simple as buying a handful of marijuana stocks on good news. Often it backfires...(MarketWatch)

February 22, 2019
UPDATE: These three marijuana stocks are rising in popularity

By Nigam Arora KushCo Holdings, Curaleaf Holdings and Acreage Holdings are beloved by the momentum crowd, but not by professional investors Marijuana has a bright future, but making money in marijuana is not as simple as buying a few stocks. (MarketWatch)

February 21, 2019
Tilray started at neutral at Seaport Global

(END) Dow Jones Newswires February 21, 2019 11:46 ET (16:46 GMT) Copyright (c) 2019 Dow Jones & Company, Inc.(MarketWatch)

UPDATE: Cannabis stocks higher as Tilray unveils biggest acquisition yet

By Ciara Linnane, MarketWatch Aurora Cannabis announces some board changes, while CannTrust says it will start trading on the NYSE next Monday Cannabis shares were mostly higher Wednesday, with Tilray Inc. in focus after it unveiled a more...(MarketWatch)

February 20, 2019
UPDATE: Tilray makes richest deal yet in effort to jump into U.S. CBD market

By Max A. Cherney Tilray plans to buy Manitoba Harvest -- which claims to be world's largest hemp-food maker -- for $317 million in cash and stock Marijuana company Tilray Inc. announced its most expensive acquisition to date early Wednesday...(MarketWatch)

Tilray's stock climbs 1.3% premarket after deal to buy Manitoba Harvest for more than $300 mln

(END) Dow Jones Newswires February 20, 2019 07:03 ET (12:03 GMT) Copyright (c) 2019 Dow Jones & Company, Inc.(MarketWatch)

February 13, 2019
UPDATE: Aurora Cannabis is a prime example of why marijuana investors should focus on money flows

By Nigam Arora With Aurora Cannabis and most other marijuana stocks, sentiment and short squeezes are directing price action Late last month, optimism was building among average investors about Aurora Cannabis' earnings. (MarketWatch)

UPDATE: Cannabis stocks rally after Aurora posts first earnings of December quarter

By Ciara Linnane, MarketWatch Investors get first look at a cannabis banking bill that Democrats are hoping to pass in 2019 Cannabis stocks were higher across the board on Tuesday, as investors digested the first earnings reports of the season...(MarketWatch)

February 11, 2019
UPDATE: How to tell when a marijuana-stock rally is real or a mirage

By Nigam Arora So-called short squeezes often play a role in the rise of marijuana stocks As marijuana stocks have rallied recently, many investors have gotten in over their heads. (MarketWatch)

Next >

Earnings Calendar and Events Data provided by |Terms of Use| © 2019 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2019. All rights reserved.